WEC
CVS icon

Winslow Evans & Crocker’s CVS Health CVS Stock Holding History

Winslow Evans & Crocker’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$765K Buy
18,245
+5,368
+42% +$349K 0.15% 157
2020
Q3 		$752K Sell
12,877
-2,160
-14% -$134K 0.19% 122
2020
Q2 		$977K Buy
15,037
+411
+3% +$25.9K 0.26% 85
2020
Q1 		$870K Buy
14,626
+6,420
+78% +$429K 0.29% 83
2019
Q4 		$612K Buy
8,206
+3,754
+84% +$264K 0.16% 135
2019
Q3 		$284K Sell
4,452
-412
-8% -$24.4K 0.08% 245
2019
Q2 		$268K Sell
4,864
-318
-6% -$17.1K 0.07% 255
2019
Q1 		$282K Sell
5,182
-618
-11% -$38.1K 0.08% 241
2018
Q4 		$382K Buy
5,800
+1,154
+25% +$86.1K 0.13% 171
2018
Q3 		$368K Hold
4,646
– – 0.11% 187
2018
Q2 		$300K Sell
4,646
-142
-3% -$9.36K 0.09% 204
2018
Q1 		$298K Sell
4,788
-54
-1% -$3.87K 0.1% 202
2017
Q4 		$351K Sell
4,842
-418
-8% -$30.4K 0.11% 189
2017
Q3 		$428K Sell
5,260
-11,704
-69% -$926K 0.14% 154
2017
Q2 		$1.36M Buy
16,964
+7,408
+78% +$585K 0.37% 62
2017
Q1 		$750K Sell
9,556
-2,934
-23% -$234K 0.24% 93
2016
Q4 		$986K Sell
12,490
-6,278
-33% -$508K 0.3% 77
2016
Q3 		$1.67M Sell
18,768
-540
-3% -$51K 0.48% 46
2016
Q2 		$1.85M Buy
19,308
+3,684
+24% +$367K 0.55% 42
2016
Q1 		$1.62M Buy
15,624
+3,224
+26% +$313K 0.49% 51
2015
Q4 		$1.21M Buy
12,400
+5,150
+71% +$504K 0.35% 66
2015
Q3 		$699K Buy
7,250
+240
+3% +$25.2K 0.22% 102
2015
Q2 		$735K Sell
7,010
-7,644
-52% -$781K 0.21% 115
2015
Q1 		$1.51M Buy
14,654
+6,956
+90% +$704K 0.43% 50
2014
Q4 		$741K Sell
7,698
-954
-11% -$84.1K 0.21% 105
2014
Q3 		$689K Buy
8,652
+587
+7% +$46.3K 0.2% 120
2014
Q2 		$608K Buy
8,065
+2,360
+41% +$178K 0.2% 124
2014
Q1 		$427K Sell
5,705
-98
-2% -$6.92K 0.15% 160
2013
Q4 		$415K Buy
+5,803
New +$373K 0.14% 174

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Winslow Evans & Crocker's CVS Position: Q4 2020 in Review

Winslow Evans & Crocker increased its CVS Health (CVS) stake by 42% in Q4 2020, buying an estimated $349K and bringing the position to 18,245 shares worth $765K. The position accounts for 0.15% of the portfolio, ranked #157.

Winslow Evans & Crocker first reported a position in CVS in Q4 2013 and has held it in 29 quarters since. The position peaked at $1.85M in Q2 2016. 1,972 funds tracked by Wall St. Rank hold CVS as of Q4 2020.

  • Winslow Evans & Crocker held 18,245 shares of CVS Health worth $765K as of Q4 2020.
  • Winslow Evans & Crocker bought 5,368 CVS Health shares in Q4 2020, an estimated $349K.
  • CVS Health made up 0.15% of Winslow Evans & Crocker's portfolio in Q4 2020, its #157 holding.
  • Winslow Evans & Crocker first reported a position in CVS Health in Q4 2013 and has held it in 29 quarters since.
  • Winslow Evans & Crocker's CVS Health position peaked at $1.85M in Q2 2016.
  • 1,972 funds tracked by Wall St. Rank held CVS Health as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.